The Trump administration’s 2025 Medicare proposal targets Part B drugs like Keytruda, prompting Merck’s lawsuit and reigniting debates over pharmaceutical…
How telehealth CEOs are responding to Congress’ latest spending legislation
Telehealth CEOs react to Congress’ temporary extension of Medicare telehealth flexibilities, emphasizing the need for permanent legislation to ensure health…
Medicare Advantage Star Ratings Drop Again
Medicare Advantage star ratings decline for another year. For the second consecutive year, the star ratings for Medicare Advantage plans…
